Brickell Biotech, Inc. (FRTX) Tops Q1 EPS by 51c

Brickell Biotech, Inc. (NASDAQ: FRTX) reported Q1 EPS of ($1.14), $0.51 better than the analyst estimate of ($1.65).

For earnings history and earnings-related data on Brickell Biotech, Inc. (FRTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c